Skip to main content
Premium Trial:

Request an Annual Quote

Ares Genetics ARESCloud

Ares Genetics, an OpGen subsidiary, has commercially launched ARESCloud, a web application aimed at accelerating the analysis of sequenced clinical isolates. The software fully auotmates data processing, from raw sequence data to report, and offers insights into epidemiologically and etiologically relevant information including pathogen identity, genotype, virulence, plasmids, and antimicrobial resistance. The news software also features tools for comparative and outbreak analysis. Under a simple subscription model users can access ARESdb, a proprietary knowledgebase containing comprehensive information on genetic and mutational AMR markers as well as advanced machine-learning models for the prediction of antibiograms directly from genomic data, the company said.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.